ESAB’s second quarter saw modest headline growth but a significant negative market reaction, as investors digested the impact of organic revenue declines and margin compression. Management pointed to strong execution in its EMEA and APAC segments, supported by recent acquisitions and robust performance across high-growth markets. However, tariff-related uncertainty in the Americas—especially in Mexico—and delayed automation orders weighed on overall volume, leading to lower organic growth. CEO Shyam Kambeyanda acknowledged these challenges, noting, “Tariff-related uncertainty introduced unexpected volume headwinds, particularly impacting our local customers in Mexico.”
ESAB (ESAB) Q2 CY2025 Highlights:
- Revenue: $715.6 million vs analyst estimates of $707.2 million (1.2% year-on-year growth, 1.2% beat)
- Adjusted EPS: $1.40 vs analyst estimates of $1.35 (4% beat)
- Adjusted EBITDA: $143.5 million vs analyst estimates of $136 million (20.1% margin, 5.5% beat)
- Management slightly raised its full-year Adjusted EPS guidance to $5.23 at the midpoint
- EBITDA guidance for the full year is $530 million at the midpoint, in line with analyst expectations
- Operating Margin: 15.2%, down from 16.9% in the same quarter last year
- Organic Revenue fell 2.2% year on year vs analyst estimates of flat growth (169.6 basis point miss)
- Market Capitalization: $6.81 billion
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our Top 5 Analyst Questions From ESAB’s Q2 Earnings Call
- Tami Zakaria (JPMorgan) asked about the breadth of tariff headwinds and the timeline for recovery in Mexico. CEO Shyam Kambeyanda explained the volume disruptions were broad-based and expects conditions to improve in the back half of the year, though recovery remains uncertain.
- Bryan Blair (Oppenheimer) questioned the underlying order trends in the Americas and the impact of delayed automation and Mexico orders. Kambeyanda stated that automation is expected to recover in the second half, while Mexico’s rebound will depend on resolving ongoing trade negotiations.
- Adam Farley (Stifel) inquired about drivers of growth in China and Southeast Asia. Kambeyanda highlighted ESAB’s exposure to energy, rail, and infrastructure, with stable business in China and improving trends in Southeast Asia and Australia.
- Neal Burk (UBS) sought details on the expected step down in incremental margins and the contribution of new products. CFO Kevin Johnson explained foreign exchange effects are the primary driver of margin compression, while new product introductions remain robust but slightly below last year due to tariff noise.
- Mircea Dobre (Baird) asked about the scale of Mexico’s impact and the split between automation and other business lines. Kambeyanda clarified that Mexico and automation together represent about 20-25% of the Americas segment, both seeing significant volume declines but with recovery expected in coming quarters.
Catalysts in Upcoming Quarters
In the quarters ahead, our team will watch (1) whether automation and Mexican order volumes return to pre-tariff levels, (2) the pace of integration and contribution from new acquisitions like EWM, DeltaP, and Aktiv, and (3) continued margin improvement from back-office optimization and productivity initiatives. The trajectory of international infrastructure and energy demand, as well as any developments in trade policy, will also be important markers of ESAB’s performance.
ESAB currently trades at $112.21, down from $132.03 just before the earnings. Is the company at an inflection point that warrants a buy or sell? .